Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clareon PanOptix vs PanOptix Pro vs Mixed PanOptix Pro/Vivity in Cataract
NCT06922084Phase 4Recruiting
- Sponsor
- Berkeley Eye Center
- Start
- Mar 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cataract (3 arms), sponsored by Berkeley Eye Center. Primary endpoint: Binocular photopic corrected distance visual acuity at 3 months. Started Mar 2025; status: recruiting.
02
Conditions
cataract
Beyond the preview
Go deeper on NCT06922084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06922084.